secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2021-07-22T23:59:59+00:00
Accession:  0001607062-21-000235
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Clinigence reappoints Mark Fawcett to board and as Compensation Committee Chairman
--------------------------------------------------------------------------------

- Reappointed July 14, 2021; holds office until next annual election.
- Fawcett is SVP & Treasurer of Fresenius Medical Care Holdings (NYSE: FMS).
- Previously served on Clinigence board Oct 2019–June 2020; replaces resigned director Randall Stern.
- Also board member of Apollo Medical Holdings (Nasdaq: AMEH) since January 2016.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000160706221000235/0001607062-21-000235-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000160706221000235/clnh072221form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-21-000235

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer